Lead the Evolution
Be a global leader in innovative protein creation
Lead the Evolution
Be a global leader in innovative protein creation
Lead the Evolution
Be a global leader in innovative protein creation
Lead the Evolution
Be a global leader in innovative protein creation
NEWS
The latest news from RevolKa Ltd.
Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
Tokyo Japan- June 23, 2023. RevolKa Ltd., a ventur...
Presenting at the AACR ANNUAL MEETING 2023
Our Senior Director, Norio Hamamatsu will be prese...
Presenting at CPHI Japan
Our Board director and CSO, Mitsuo Umetsu will be ...
Presentation movie uploaded at Antibody Engineering & Therapeutics
Uploaded a Presentation movie by Our Senior Direct...
ABOUT US

RevolKa is a pioneer of next-generation protein engineering. We are committed to the discovery and development of innovative proteins by leveraging a proprietary artificial intelligence-integrated directed protein evolution technology, called aiProtein®.
TECHNOLOGY

About directed protein evolution
Since four billion years ago, the vast diversity of life has been created on the Earth. The evolution of species is driven by adaptation to environmental changes. We, human beings, have unlocked the mysteries of molecular mechanisms of evolution and innovated a brilliant technology, called directed protein evolution, which is an accelerated molecular evolution of proteins in laboratories. Three distinguished scientists, Prof. George Smith, Prof. Gregory Winter, and Prof. Frances Arnold were awarded the 2018 Novel prize in chemistry for directed protein evolution.

About aiProtein®
RevolKa innovatively integrated directed protein evolution with the transformative digital technology, artificial intelligence. aiProtein® remarkably accelerates directed protein evolution and enables the creation of unprecedented engineered proteins. RevolKa has also successfully achieved simultaneous multi-dimensional engineering by using aiProtein®.
RevolKa’s proprietary technology,
aiProtein® is a powerful and efficient tool for multi-dimensional engineering of proteins.
PARTNERSHIP
Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
Tokyo Japan- June 23, 2023. RevolKa Ltd., a ventur...
Started a joint research collaboration with Tokyo Medical and Dental University
TOKYO, Japan – 1st October 2022. RevolKa Ltd., a v...
Concluded a joint research agreement with Sumitomo Dainippon Pharma
TOKYO,Japan – 24 March, 2022. RevolKa Ltd., a biot...